Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening of V617F mutation in JAK2 gene with acute myeloid leukemia in the Saudi population.

Acta biochimica Polonica - 21 Feb 2022

Farasani Abdullah

Abstract excerpt

Progress in pathogenesis and therapy of acute myeloid leukemia (AML) is presently accelerating. The Janus kinase 2 gene (JAK2) mutations are rare in de novo AML. The gene codes for the tyrosine kinase that has a significant role in the signal transduction in hematopoietic cells. The aim of this study was to induce V617F mutation in the JAK2 gene in the AML patients diagnosed in the Saudi population. In this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Case-Control Studies
Share to Genotyping Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Leukemia, Myeloid, Acute

Share to Mass Screening

Share to Saudi Arabia

Share to Young Adult

Source

Identifiers

PMID: 35189054
DOI: 10.18388/abp.2020_5945

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening of V617F mutation in JAK2 gene with acute myeloid leukemia in the Saudi population.PMID 35189054Read ↗

Acquired mutation of the tyrosine kinase JAK2V617F in Egyptian patients with myeloid disorders.Semantic proximity Read ↗

Prevalence of JAK 2 v617 Mutations in Malignant and Non-Malignant Tumors in the Eastern Province of the Kingdom of Saudi Arabia.Semantic proximity Read ↗

[Research advances in the role of JAK2 mutations in acute leukemia].Semantic proximity Read ↗

Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.Semantic proximity Read ↗

JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population.Semantic proximity Read ↗

The JAK2 V617F mutation in de novo acute myelogenous leukemiasSemantic proximity Read ↗

Morphologic and Molecular Characteristics of De Novo AML With JAK2 V617F Mutation.Semantic proximity Read ↗

Identification of somatic JAK1 mutations in patients with acute myeloid leukemia.Semantic proximity Read ↗

JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: contribution, diagnosis and therapeutic prospects.Semantic proximity Read ↗

JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia.Semantic proximity Read ↗

The associations of Janus kinase-2 (JAK2) A830G polymorphism and the treatment outcomes in patients with acute myeloid leukemia.Semantic proximity Read ↗

[Detection of JAK2V617F mutation and its clinical significance in 80 patients with M2 acute myelogenous leukemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.